platform
-
Recon
Orthopedic Care Partners Adds Physician Practice and Clinic Location to its Missouri-Based Motion Orthopaedics Platform and Hires Seven Surgeons Across Arizona, Colorado and Florida
April 4, 2022 GAINESVILLE, Fla.–(BUSINESS WIRE)–Orthopedic Care Partners (OCP), a strategic partner and support organization for top-performing orthopedic practices currently…
Read More » -
Spine
Aurora Spine Corporation Announces Co-Marketing Agreement for its DEXA Platform with Echolight Medical
Aurora Spine’s DEXA Technology patient-matched implants supported by Echolight’s newest technologies in bone health assessment CARLSBAD, Calif., Feb. 24, 2022…
Read More » -
Hospitals
ORHub Prepares For New Platform Launch
“ORHub aims for Q2, 2022 to bring total implant accountability to the medical device & surgical industry” IRVINE, CA –…
Read More » -
Recon
AAOE Adds MotionMD® by DJO® Software Platform to the Peer Review Program™ for Orthopedic and Musculoskeletal Vendors
AAOE’s Peer Review Process creates a unique opportunity for vendors to enhance their reputation and foster deeper, more meaningful relationships…
Read More » -
Recon
LimaCorporate Receives Regulatory Approvals For Smart Space Digital Platform
SAN DANIELE DEL FRIULI, Italy, Feb. 11, 2021 /PRNewswire/ — LimaCorporate makes important strides in the development of its digital platform designed to assist…
Read More » -
Financial
New Study to Evaluate Virtual Rehabilitation Platform for Physical Therapy after Total Knee Replacement Surgery
November 29, 2016 – SAN DIEGO–(BUSINESS WIRE)– Reflexion Health, Inc., a digital healthcare company, in conjunction with the Duke Clinical Research…
Read More » -
Financial
Zimmer Biomet Acquires RespondWell® Telerehabilitation Platform for Zimmer Biomet Signature Solutions™
(WARSAW, IN) October 27, 2016—Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced…
Read More » -
Hospitals
Implanet strengthens intellectual property protection of JAZZ through 2032 by obtaining a key United States patent
Bordeaux, Boston, August 30, 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in…
Read More »